Target intelligence / Profile preview

RNA, U6 small nuclear 869, pseudogene (RNU6-869P)

Target
RNU6-869P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNU6-869P refers to a **pseudogene** of the U6 small nuclear RNA (U6 snRNA) gene family. The U6 snRNA is a highly conserved, essential non-coding RNA component of the spliceosome, responsible for catalyzing the removal of introns from precursor mRNA in eukaryotic cells[1][3]. However, **pseudogenes** like RNU6-869P are DNA segments similar in sequence to functional genes but are typically non-functional due to mutations or lack of regulatory elements[5]. There is no evidence that RNU6-869P encodes a functional RNA or protein, nor is it considered a therapeutic target, receptor, or biomarker. The designation "869" indicates a specific locus or variant within the large family of U6 snRNA pseudogenes, which are common in vertebrate genomes and reflect the evolutionary importance of U6 snRNA[3][5]. No literature describes any role for RNU6-869P in biological processes, disease, or drug interaction. There is also no evidence that this pseudogene is expressed or produces a functional snRNA variant. Thus, it is not a relevant molecular target in therapeutics or research. The only potential source of confusion is that the name closely resembles functional snRNAs, but the addition of "pseudogene" or "P" at the end clearly denotes it as non-functional[5].

Other names
RNU6-869PU6 pseudogene 869RNA, U6 small nuclear 869 pseudogene
02

Biological functions

Other (likely none; as a pseudogene, it does not have a known functional product)
03

Disease associations

Other (no known direct role in disease, typical for pseudogenes)

Beyond the preview

Go deeper on RNA, U6 small nuclear 869, pseudogene (RNU6-869P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 869, pseudogene (RNU6-869P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call